Skip to content
October 28, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Unveiling a Malignant Alliance: Oklahoma Researchers Discover How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth unveiling-a-malignant-alliance-oklahoma-researchers-discover-how-aggressive-breast-cancer-hijacks-the-immune-system-to-fuel-growth
  • Medical Research and Clinical Trials

Unveiling a Malignant Alliance: Oklahoma Researchers Discover How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

Nila Kartika Wati October 12, 2026
NORMAN, OK – In a significant stride toward understanding and combating one of the most aggressive forms...
Read More Read more about Unveiling a Malignant Alliance: Oklahoma Researchers Discover How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth
Bridging the Divide: Experts Chart a Course for Transformative Women’s Health Innovation bridging-the-divide-experts-chart-a-course-for-transformative-womens-health-innovation
  • Medical Research and Clinical Trials

Bridging the Divide: Experts Chart a Course for Transformative Women’s Health Innovation

Muslim October 12, 2026
London, UK – October 8, 2026 – Despite significant strides in addressing women’s health inequities, a critical...
Read More Read more about Bridging the Divide: Experts Chart a Course for Transformative Women’s Health Innovation
Navigating the Nexus: GLP-1 Medications and Breast Cancer – What the Science Says navigating-the-nexus-glp-1-medications-and-breast-cancer-what-the-science-says
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – What the Science Says

Ali Ikhwan October 12, 2026
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) In recent years, glucagon-like peptide-1 (GLP-1)...
Read More Read more about Navigating the Nexus: GLP-1 Medications and Breast Cancer – What the Science Says
Global Skyline to Glow in Teal, Green, and Pink: The 2026 #LightUpMBC Campaign Targets Metastatic Breast Cancer Research global-skyline-to-glow-in-teal-green-and-pink-the-2026-lightupmbc-campaign-targets-metastatic-breast-cancer-research
  • Patient Advocacy and Support

Global Skyline to Glow in Teal, Green, and Pink: The 2026 #LightUpMBC Campaign Targets Metastatic Breast Cancer Research

Sagoh October 12, 2026
NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo...
Read More Read more about Global Skyline to Glow in Teal, Green, and Pink: The 2026 #LightUpMBC Campaign Targets Metastatic Breast Cancer Research
FDA Approves Tucatinib Triple-Combination for HER2-Positive Metastatic Breast Cancer: A Paradigm Shift in Maintenance Therapy Set iv fluid intravenous drop saline drip hospital room,Medical Concept,treatment emergency and injection drug infusion care chemotherapy, concept.blue light background,selective focus stock photo
  • Patient Advocacy and Support

FDA Approves Tucatinib Triple-Combination for HER2-Positive Metastatic Breast Cancer: A Paradigm Shift in Maintenance Therapy

Lina Irawan October 12, 2026
The landscape of HER2-positive metastatic breast cancer (MBC) treatment has reached a significant milestone. The U.S. Food...
Read More Read more about FDA Approves Tucatinib Triple-Combination for HER2-Positive Metastatic Breast Cancer: A Paradigm Shift in Maintenance Therapy
Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for October 2026 navigating-the-new-normal-breast-cancer-canada-announces-comprehensive-survivorship-webinar-series-for-october-2026-2
  • Patient Advocacy and Support

Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for October 2026

Suro Senen October 12, 2026
TORONTO — As the landscape of oncology shifts from a singular focus on acute treatment toward a...
Read More Read more about Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for October 2026
Strengthening Resilience: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership and Humanitarian Solidarity strengthening-resilience-who-director-generals-state-visit-to-jordan-highlights-global-health-leadership-and-humanitarian-solidarity
  • Breast Cancer Prevention and Lifestyle

Strengthening Resilience: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership and Humanitarian Solidarity

Iffa Jayyana October 12, 2026
AMMAN, Jordan – The World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, has concluded the first...
Read More Read more about Strengthening Resilience: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership and Humanitarian Solidarity
Breakthrough in Celiac Disease: First Tracks’ ANB033 Signals Potential Paradigm Shift in Autoimmune Treatment breakthrough-in-celiac-disease-first-tracks-anb033-signals-potential-paradigm-shift-in-autoimmune-treatment
  • Treatment Innovations

Breakthrough in Celiac Disease: First Tracks’ ANB033 Signals Potential Paradigm Shift in Autoimmune Treatment

Asro October 12, 2026
By Delilah Alvarado | October 12, 2026 In a significant development for the millions of people living...
Read More Read more about Breakthrough in Celiac Disease: First Tracks’ ANB033 Signals Potential Paradigm Shift in Autoimmune Treatment
Stryker’s Strategic Leap: A $400M Bet on the Future of Soft-Tissue Robotics strykers-strategic-leap-a-400m-bet-on-the-future-of-soft-tissue-robotics
  • Treatment Innovations

Stryker’s Strategic Leap: A $400M Bet on the Future of Soft-Tissue Robotics

Raul Delapena Setiawan October 12, 2026
In a landmark move that signals a significant shift in the competitive landscape of medical technology, Michigan-based...
Read More Read more about Stryker’s Strategic Leap: A $400M Bet on the Future of Soft-Tissue Robotics
The Digital Renaissance: Mining Archived Tissue to Revolutionize Preclinical Research the-digital-renaissance-mining-archived-tissue-to-revolutionize-preclinical-research
  • Treatment Innovations

The Digital Renaissance: Mining Archived Tissue to Revolutionize Preclinical Research

Ali Ikhwan October 12, 2026
In the landscape of modern drug discovery, the traditional approach to toxicology and pathology has long been...
Read More Read more about The Digital Renaissance: Mining Archived Tissue to Revolutionize Preclinical Research

Posts pagination

Previous 1 … 90 91 92 93 94 95 96 … 832 Next

Recent Posts

  • The Agentic Revolution: New Analysis Quantifies Massive ROI for AI in Clinical Trials
  • Revolutionary Antibiotic Combination Shows Promise in Combating Drug-Resistant Infections
  • Black Women Forge Sisterhood and Drive Impact Through Breast Cancer Advocacy
  • Empowering the Next Generation: CAKES Body Pledges New $250,000 Commitment to Breast Cancer Research for Young Women
  • Strengthening Global Health Equity: Qatar and WHO Forge Strategic Financial Partnership

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

the-agentic-revolution-new-analysis-quantifies-massive-roi-for-ai-in-clinical-trials
  • Chemotherapy and Targeted Therapy

The Agentic Revolution: New Analysis Quantifies Massive ROI for AI in Clinical Trials

Basiran October 28, 2026
revolutionary-antibiotic-combination-shows-promise-in-combating-drug-resistant-infections
  • Medical Research and Clinical Trials

Revolutionary Antibiotic Combination Shows Promise in Combating Drug-Resistant Infections

Muslim October 28, 2026
black-women-forge-sisterhood-and-drive-impact-through-breast-cancer-advocacy
  • Patient Advocacy and Support

Black Women Forge Sisterhood and Drive Impact Through Breast Cancer Advocacy

Jia Lissa October 28, 2026
empowering-the-next-generation-cakes-body-pledges-new-250000-commitment-to-breast-cancer-research-for-young-women
  • Patient Advocacy and Support

Empowering the Next Generation: CAKES Body Pledges New $250,000 Commitment to Breast Cancer Research for Young Women

Nila Kartika Wati October 28, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.